The CeO2/Nrf2 nanocomposites demonstrated superior effects in mitigating cardiac dysfunction, reducing infarct size, and attenuating cardiac remodeling post-MI compared to pristine ceria nanoparticles. This evidence concerns the gene NFE2L2 and myocardial infarction.